Many women with early-stage forms of the disease can forego chemo, based on a test that measures the activity of genes involved in breast cancer recurrence. To speak to this, Dr. Sara Keck, MD is an oncology specialist in Santa Rosa, and has been practicing for 12 years. She graduated from New York Med Coll in 2006 and specializes in oncology and medical oncology.
Dr. Keck speaks to how this could change treatment going forward for women over fifty, the percentage of women who wouldn’t have to undergo chemo any longer, what doctors have learned about the “personality” (biology) of cancer cells, the turn toward personalizing treatment for those diagnosed with cancer, what kind of questions woman should ask if they’ve been recently diagnosed, and what other advances are being discovered in cancer research:
